People: MEDNAX Inc (MD)

MD on New York Consolidated

60.00USD
23 Apr 2014
Price Change (% chg)

$-0.37 (-0.61%)
Prev Close
$60.37
Open
$60.34
Day's High
$60.58
Day's Low
$59.98
Volume
465,832
Avg. Vol
628,146
52-wk High
$64.51
52-wk Low
$42.74

Search Stocks

Summary

Name Age Since Current Position

Cesar Alvarez

66 2004 Chairman of the Board

Joseph Calabro

52 2004 President, Chief Operating Officer

Roger Medel

66 2004 Chief Executive Officer, Director

Vivian Lopez-Blanco

55 2010 Chief Financial Officer, Treasurer

Michael Stanley

66 2012 President - Pediatrix Division

Karl Wagner

47 2010 President - American Anesthesiology

Dominic Andreano

44 2012 Senior Vice President, General Counsel, Secretary

David Clark

46 2009 Chief Operating Officer - Pediatrix Division

Waldemar Carlo

60 1999 Independent Director

Michael Fernandez

60 1995 Independent Director

Roger Freeman

77 2002 Independent Director

Paul Gabos

48 2002 Independent Director

Pascal Goldschmidt

58 2006 Independent Director

Manuel Kadre

47 2007 Independent Director

Donna Shalala

72 2010 Independent Director

Enrique Sosa

72 2004 Independent Director

David Parker

47 Vice President - Investor Relations & Corporate Communications

Biographies

Name Description

Cesar Alvarez

Mr. Cesar L. Alvarez is Chairman of the Board of Mednax Inc. He has been a Director since March 1997 and was elected as Chairman of the Board of Directors in May 2004. Mr. Alvarez has served since February 2012 as Co-Chairman of the international law firm of Greenberg Traurig, P.A. and previously served as its Chief Executive Officer from 1997 until his election as Executive Chairman in January 2010 and as its Executive Chairman from January 2010 until his election as Co-Chairman. Mr. Alvarez also serves on the Board of Directors of Watsco, Inc. and Fairholme Funds, Inc. Mr. Alvarez served as a director of Atlantis Plastics, Inc. from 1995 until 2008 and as a director of New River Pharmaceuticals, Inc. from 2004 until 2007.

Joseph Calabro

Mr. Joseph M. Calabro is President, Chief Operating Officer of Mednax, Inc. He joined the Company in January 1996 as Chief Information Officer. In January 2000, Mr. Calabro was appointed Executive Vice President, Management, in May 2000, he was appointed Chief Operating Officer, and in May 2004, he was appointed President. Prior to joining the Company, Mr. Calabro served as Director of Information Technology for the Ambulatory Surgery Group of Columbia/HCA. He served in various operational and technology positions for various healthcare companies from 1987 to 1994.

Roger Medel

Dr. Roger J. Medel, M.D., is Chief Executive Officer, Director of Mednax Inc. He has been a Director of the Company since he co-founded it in 1979. Dr. Medel served as the Company’s President until May 2000 and as Chief Executive Officer until December 2002. In March 2003, Dr. Medel reassumed the position of President, serving in that position until May 2004, and Chief Executive Officer, a position in which he continues to serve today. Dr. Medel was a member of the Board of Trustees of the University of Miami from January 2004 to February 2012. Dr. Medel participates as a member of several medical and professional organizations and, from June 2006 to April 2009, served on the Board of Directors of MBF Healthcare Acquisition Corp.

Vivian Lopez-Blanco

Ms. Vivian Lopez-Blanco is Chief Financial Officer, Treasurer of Mednax, Inc. She joined the Company in May 2008 as Vice President and Treasurer and was appointed Chief Financial Officer in January 2010. Prior to joining the Company, from 2003 to 2008, Ms. Lopez-Blanco served as Chief Financial Officer of Carrols Corporation’s Hispanic Restaurants Division, which includes the Pollo Tropical and Taco Cabana concepts. Ms. Lopez-Blanco joined Pollo Tropical in 1997 as Controller, was promoted to Chief Financial Officer in 1998 and led the Company through its acquisition by Carrols. Prior to Pollo Tropical, Ms. Lopez-Blanco served in a variety of positions with an international accounting firm. Ms. Lopez-Blanco is a certified public accountant.

Michael Stanley

Dr. Michael D. Stanley, M.D., is President - Pediatrix Division of Mednax, Inc. He joined the Company in 1997 and became President of Company's Pediatrix Division in February 2012. Dr. Stanley previously served as Company's Regional President, South Central Region for the Pediatrix Division from January 2002 until February 2012 and prior thereto as Company's Vice President of Medical Operations, South Central Region. Dr. Stanley is board certified in pediatrics and neonatal-perinatal medicine.

Karl Wagner

Mr. Karl B. Wagner is President - American Anesthesiology of Mednax, Inc. He joined the Company in May 1997 and became President of Company's American Anesthesiology Division in January 2010. Mr. Wagner was appointed Chief Financial Officer and Treasurer in August 1998 and served as the Company’s Chief Financial Officer from August 1998 until December 2009, and as Treasurer from August 1998 until May 2008. Prior to his appointment, Mr. Wagner served as the Company’s Controller. Prior to joining the Company, Mr. Wagner was Chief Financial Officer for the East Region of Columbia/HCA’s Ambulatory Surgery Group from January 1995 until May 1997. From July 1993 through January 1995, Mr. Wagner was Assistant Controller of Medical Care International, Inc., a subsidiary of Medical Care America, Inc.

Dominic Andreano

Mr. Dominic J. Andreano is Senior Vice President, General Counsel, Secretary of Mednax, Inc., since May 2012. He joined the Company in September 2001. Prior to his appointment, Mr. Andreano previously served as Deputy General Counsel for the Company from January 2009 until May 2012, as Associate General Counsel for the Company from January 2004 until December 2008, and prior thereto as Director, Business Development. Prior to joining the Company, Mr. Andreano was an associate in the corporate securities department of Holland & Knight, LLP in Miami from June 2000 until September 2001, and an associate in the health care corporate department of Greenberg Traurig, P.A. in Miami from September 1997 until June 2000.

David Clark

Mr. David A. Clark is Chief Operating Officer - Pediatrix Division of Mednax, Inc. He joined the Company in May 2001 and has been Chief Operating Officer of Company's Pediatrix Division since August 2008 with executive officer responsibilities since January 1, 2009. Mr. Clark served as Senior Vice President, Operations from December 2003 until August 2008, and as Vice President of Operations, South Central Region from November 2001 to November 2003. From June 2000 to October 2001, Mr. Clark was Vice President of Operations for Magella Healthcare, which the Company acquired in 2001, and prior thereto he was Vice President of Business Development for Magella Healthcare. Mr. Clark is a certified public accountant.

Waldemar Carlo

Dr. Waldemar A. Carlo, M.D., is Independent Director of Mednax, Inc., since June 1999. Dr. Carlo has served as Professor of Pediatrics and Director of the Division of Neonatology at the University of Alabama School of Medicine since 1991. Dr. Carlo participates as a member of several medical and professional organizations. He has received numerous research awards and grants and has lectured, both nationally and internationally.

Michael Fernandez

Mr. Michael B. Fernandez is Independent Director of Mednax, Inc., since October 1995. Mr. Fernandez has served as Chairman and is and has been a Managing Director of MBF Healthcare Partners, L.P., a private equity firm focused on investing in healthcare service companies, since February 2005. He is also the Chairman of Simply Healthcare Holdings and Navarro Discount Pharmacies, LLC. Mr. Fernandez previously served as Chairman and Chief Executive Officer of CarePlus Health Plans Inc., a managed care HMO, from January 2003 until February 2005, as Chairman and Chief Executive Officer of Physicians Healthcare Plans, Inc., a Florida-based HMO, from 1992 until December 2002, and as Chairman and Chief Executive Officer of MBF Healthcare Acquisition Corp. from June 2006 until April 2009. Mr. Fernandez has served as a member of the Board of Trustees of the University of Miami and was on the Board of Directors of various private entities, including Healthcare Atlantic, Inc., a holding company that operates various health care entities.

Roger Freeman

Dr. Roger K. Freeman, M.D., is Independent Director of Mednax, Inc., since May 2002. Dr. Freeman is a maternal-fetal medicine physician and is currently an Assistant Professor of Obstetrics and Gynecology at the University of California - Irvine. In 1975, he founded Perinatal Associates of Southern California, a physician practice group that has been affiliated with the Company since Company acquired Magella Healthcare Corporation (“Magella Healthcare”) in May 2001. In September 1999, Dr. Freeman retired from the private practice of medicine. Dr. Freeman has served on many national and local obstetrics and gynecology and maternal-fetal organizations. He is currently a member of the Long Beach Memorial Medical Center Foundation Board and serves on the Board of Directors of Todd Cancer Institute at Long Beach Memorial Hospital. Dr. Freeman has authored numerous articles and three books.

Paul Gabos

Mr. Paul G. Gabos is Independent Director of Mednax, Inc., since November 2002. Mr. Gabos served as Chief Financial Officer of Lincare Holdings Inc. (“Lincare”) from June 1997 until December 2012, after its merger with a subsidiary of Linde AG, and prior thereto served as Vice President — Administration for Lincare. Prior to joining Lincare in 1993, Mr. Gabos worked for Coopers & Lybrand and for Dean Witter Reynolds, Inc.

Pascal Goldschmidt

Dr. Pascal J. Goldschmidt, M.D., is Independent Director of Mednax Inc., since March 2006. Dr. Goldschmidt has been the Chief Executive Officer of the University of Miami Health System since November 2007 and the Senior Vice President for Medical Affairs and Dean of the University of Miami Leonard M. Miller School of Medicine since April 2006. Previously, Dr. Goldschmidt was a faculty member with the Department of Medicine at Duke University Medical Center where he served as Chairman from 2003 to 2006 and as Chief of the Division of Cardiology from 2000 to 2003. Dr. Goldschmidt currently serves on the Board of Directors of Health Management Associates and previously served as a director for Opko Health, Inc. from 2007 until 2011.

Manuel Kadre

Mr. Manuel Kadre is an Independent Director of Mednax, Inc., since May 2007. Mr. Kadre has been the Chief Executive Officer of Gold Coast Caribbean Importers, LLC since July 2009 and Chairman and Chief Executive Officer of MBB Auto LLC since December 2012. From 1995 until July 2009, Mr. Kadre served as Vice President, General Counsel and Secretary of CC1 Companies, Inc., which distributes Coca-Cola and other beverage products in markets throughout the Caribbean. Mr. Kadre also serves on the Board of Trustees of the University of Miami and the Board of Governors of University of Miami Hospital and previously served as a director of Equity Media Holdings Corporation from April 2007 until December 2008.

Donna Shalala

Ms. Donna E. Shalala, Ph.D., is Independent Director of Mednax, Inc., since May 2010. Dr. Shalala has served as the President of the University of Miami and Professor of Political Science at the University of Miami since 2001. From 1993 until 2001, Dr. Shalala served as the United States Secretary of Health and Human Services. Dr. Shalala served as Chancellor and Professor of Political Science at the University of Wisconsin-Madison from 1987 to 1993 and as President and Professor of Political Science at Hunter College from 1980 to 1987. From 1977 to 1980, Dr. Shalala served as Assistant Secretary of the Department of Housing and Urban Development. Dr. Shalala is a member of the Institute of Medicine of the National Academy of Medicine. Dr. Shalala served as a director of Lennar Corporation from 2001 to April 2012, as a director of Gannett Co., Inc. from 2001 until 2007 and as a director of UnitedHealth Group Incorporated from 2001 to 2011.

Enrique Sosa

Dr. Enrique J. Sosa, Ph.D., is an Independent Director of Mednax, Inc., since May 2004. Dr. Sosa, who is presently retired, served as President of BP Amoco Chemicals from January 1999 to April 1999. From 1995 to 1998, he was Executive Vice President of Amoco Corporation. Prior to joining Amoco, Dr. Sosa served as Senior Vice President of The Dow Chemical Company, President of Dow North America and a member of its Board of Directors. Dr. Sosa was a Director of FMC Corporation from June 1999 until April 2012 and a Director of Northern Trust Corporation from April 2007 until April 2012.

David Parker

Search Stocks